This study substantially advanced the goal of fully automated small-molecule synthesis. A major bottleneck had been the lack of robust, automation-friendly building blocks for iteratively forming Csp³–C bonds — a type of bond common in natural products and complex, drug-like molecules. The authors introduced a redesigned boronate platform based on TIDA boronates that are 1000 times more stable than their MIDA boronate counterparts under demanding reaction conditions, while still supporting reliable, iterative assembly.
Because these new building blocks tolerate stereospecific Csp³ coupling chemistry, they extend blocc chemistry for automated synthesis far beyond prior limits. In practical terms, this makes multi-step modular assembly of small molecules more predictable and repeatable for machines.
The broader outcome is a more robust and scalable path to complex, Csp³-rich molecules through automated workflows. If adopted widely, this approach could shorten timelines for pharmaceutical and materials discovery by enabling push-button access to diverse molecular structures that previously required heavy manual effort by artisans.
